189 related articles for article (PubMed ID: 15371950)
21. Imaging findings of ovarian dysgerminoma with emphasis on multiplicity and vascular architecture: pathogenic implications.
Tsuboyama T; Hori Y; Hori M; Onishi H; Tatsumi M; Sakane M; Ota T; Tomiyama N
Abdom Radiol (NY); 2018 Jul; 43(7):1515-1523. PubMed ID: 29450608
[TBL] [Abstract][Full Text] [Related]
22. Expression of Transcription Factors and Nuclear Receptors in Mixed Germ Cell-Sex Cord Stromal Tumor and Related Tumors of the Gonads.
Roth LM; Cheng L
Int J Gynecol Pathol; 2015 Nov; 34(6):528-34. PubMed ID: 26107563
[TBL] [Abstract][Full Text] [Related]
23. Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Hsieh DS; Loh SH; Chen A; Yao CW; Yen CY
Mod Pathol; 2006 Mar; 19(3):447-52. PubMed ID: 16439987
[TBL] [Abstract][Full Text] [Related]
24. COX-2 expression in nonepithelial ovarian malignancies.
Menczer J; Schreiber L; Sukmanov O; Czernobilsky B; Berger E; Golan A; Levi T
Int J Gynecol Pathol; 2011 Jan; 30(1):41-5. PubMed ID: 21131835
[TBL] [Abstract][Full Text] [Related]
25. Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma: a clinicopathologic and immunohistochemical study of five cases.
Young RH; Hart WR
Am J Surg Pathol; 1998 Jul; 22(7):805-15. PubMed ID: 9669343
[TBL] [Abstract][Full Text] [Related]
26. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry.
Cheng L
Cancer; 2004 Nov; 101(9):2006-10. PubMed ID: 15386301
[TBL] [Abstract][Full Text] [Related]
27. Oct4 expression in immature teratoma of the ovary: relevance to histologic grade and degree of differentiation.
Abiko K; Mandai M; Hamanishi J; Matsumura N; Baba T; Horiuchi A; Mikami Y; Yoshioka S; Wakasa T; Shiozawa T; Konishi I
Am J Surg Pathol; 2010 Dec; 34(12):1842-8. PubMed ID: 21107090
[TBL] [Abstract][Full Text] [Related]
28. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
[TBL] [Abstract][Full Text] [Related]
29. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary.
Rishi M; Howard LN; Bratthauer GL; Tavassoli FA
Am J Surg Pathol; 1997 May; 21(5):583-9. PubMed ID: 9158684
[TBL] [Abstract][Full Text] [Related]
30. New and unusual aspects of ovarian germ cell tumors.
Young RH
Am J Surg Pathol; 1993 Dec; 17(12):1210-24. PubMed ID: 7694512
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications.
Sever M; Jones TD; Roth LM; Karim FW; Zheng W; Michael H; Hattab EM; Emerson RE; Baldridge LA; Cheng L
Mod Pathol; 2005 Nov; 18(11):1411-6. PubMed ID: 16056250
[TBL] [Abstract][Full Text] [Related]
32. Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update.
Ulbright TM
Int J Gynecol Pathol; 2014 Jul; 33(4):365-73. PubMed ID: 24901396
[TBL] [Abstract][Full Text] [Related]
33. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
[TBL] [Abstract][Full Text] [Related]
34. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
[TBL] [Abstract][Full Text] [Related]
35. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
Huang W; Cheng X; Ji J; Zhang J; Li Q
Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
[TBL] [Abstract][Full Text] [Related]
36. Gonadoblastoma with contralateral dysgerminoma in a young female--a case report.
Jadhav MN; Yelikar BR; Karigoudar M
Indian J Pathol Microbiol; 2006 Apr; 49(2):274-6. PubMed ID: 16933739
[TBL] [Abstract][Full Text] [Related]
37. [Germinal cell tumors in young and adolescent girls].
Rzepka-Górska I; Błogowska A; Zajaczek S; Zielińska D
Ginekol Pol; 2003 Sep; 74(9):840-6. PubMed ID: 14674134
[TBL] [Abstract][Full Text] [Related]
38. Bilateral dysgerminoma associated with gonadoblastoma and sex-cord stromal tumour with annular tubules in a 28-year-old fertile woman with normal karyotype.
Young KM; Scurry J; Jaaback K; Bowden NA; Scott RJ
Pathology; 2012 Apr; 44(3):257-60. PubMed ID: 22437743
[No Abstract] [Full Text] [Related]
39. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
Heckl M; Schmoeckel E; Hertlein L; Rottmann M; Jeschke U; Mayr D
PLoS One; 2018; 13(2):e0192881. PubMed ID: 29451900
[TBL] [Abstract][Full Text] [Related]
40. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
